‘I can interpret my own pathology slides — I knew I had months to live’
The story of Professor Richard Scolyer, diagnosed with a grade 4 IDH-wildtype glioblastoma, has been across the news.
It is a story of deep tragedy — nobody survives the diagnosis — but also optimism.
Professor Scolyer hopes it will show that the immunotherapy that has transformed outcomes for melanoma over the past 20 years can successfully treat the worst form of brain cancer and save his own life.
The media excitement has been significant — after all, Professor Scolyer is co-medical director of the Melanoma Institute Australia.
